Trials / Completed
CompletedNCT02370927
PERFECT Project - Part 2 - Study 2
Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objectives are to test the acute effects of different cereals containing pulse ingredients on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite to an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of cereals containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of cereals containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control | Non pulse extruded cereal |
| OTHER | Pea protein | Pulse extruded cereal |
| OTHER | Pea Starch | Pulse extruded cereal |
| OTHER | Pea fibre + pea starch | Pulse extruded cereal |
| OTHER | Pea protein + pea starch | Pulse extruded cereal |
| OTHER | Pea fibre + pea starch + pea protein | Pulse extruded cereal |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-07-01
- Completion
- 2017-12-01
- First posted
- 2015-02-25
- Last updated
- 2023-01-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02370927. Inclusion in this directory is not an endorsement.